GPC3 and hepatocellular carcinoma: This specificity makes GPC3 suitable as a tumor antigen for targeted therapy.211 Many anti-GPC3 monoclonal antibodies target the GPC3 molecule that recognizes the HCC cell membrane structure, leading to antibody-mediated endocytosis.